IL17B and neoplasm: Importantly, in each study, inhibition of the IL-17B/IL-17RB axis by downregulating receptor expression in tumor cells or by using neutralizing anti-IL-17RB antibodies restored chemosensitivity in vitro (28, 38) and in vivo (10).